Primary graft dysfunction (PGD or lung reperfusion edema) complicates 10 to 20% of lung transplantations and leads to severe early and late postoperative complications. Its pathophysiology remains unclear but may involve graft ischemia-reperfusion, increased vascular permeability, pneumocyte dysfunction and finally alveolar flooding that impair gas exchange and blood oxygenation.Its substrate, namely extravascular lung water (EVLW), can now be clinically measured with minimally invasive Intensive Care Unit monitors (PiCCO2®, Pulsion Medical Systems) that also provides a physical estimate of pulmonary vascular permeability (PVPI). Similarly, biochemical correlates of vascular permeability (ICAM-1) and pneumocyte dysfunction (RAGE) can now be measured in plasma samples. Our study aims at quantifying physical and biochemical markers of PGD and assess their diagnosis and prognosis values.
Study Type
OBSERVATIONAL
Enrollment
45
Service d'Anesthésie-Réanimations chirurgicales - Nouvel Hôpital Civil - Hôpitaux Universitaires de Strasbourg
Strasbourg, France
RECRUITINGService de Chirurgie thoracique - Nouvel Hôpital Civil - 1, Place de l'hôpital
Strasbourg, France
RECRUITINGService de Physiologie et d'Explorations fonctionnelles - Nouvel Hôpital Civil - 1, Place de l'hôpital
Strasbourg, France
RECRUITINGService de Pneumologie - Nouvel Hôpital Civil -1, Place de l'hôpital
Strasbourg, France
RECRUITINGDiagnosis and prognosis values of extravascular lung water (EVLW) and pulmonary vascular permeability index (PVPI).
Time frame: H0 (At started lung transplantation), H6, H12, H24, H48, H72 after lung transplantation
Diagnosis and prognosis values of receptor for advanced glycation endproducts (RAGE) and intercellular adhesion
Time frame: H0 (At started lung transplantation), H6, H12, H24, H48, H72 after lung transplantation
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.